Clinical Trials Logo

Metastatic Chordoma clinical trials

View clinical trials related to Metastatic Chordoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05041127 Recruiting - Chordoma Clinical Trials

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Start date: May 27, 2022
Phase: Phase 2
Study type: Interventional

This is a multicenter, single arm, phase 2 study designed to evaluate the efficacy and safety of cetuximab for the treatment of advanced (unresectable)/metastatic, chordoma. The target patient population will be any chordoma patient 18 years of age with locally unresectable disease or metastatic disease.